What is the function of red blood cells?

Function of Red Blood Cells

Red blood cells (RBCs) serve as the body's primary oxygen delivery system through hemoglobin, while also performing critical non-canonical functions including carbon dioxide transport, blood flow regulation, hemostasis, redox balance, and immune response. 1

Canonical Functions: Gas Exchange

Oxygen Transport

• Hemoglobin, the most abundant protein in erythrocytes, delivers oxygen to all tissues and organs, which is essential for cellular ATP synthesis through oxidative phosphorylation. 1
• RBCs are fundamentally responsible for oxygen transport to all cells and tissues, making them key cells in the body's respiratory system. 2, 3
• The oxygen-carrying capacity of hemoglobin is critical for tissue oxygenation, working in conjunction with cardiac output and oxygen availability in the lungs. 4

Carbon Dioxide Transport and Acid-Base Balance

• Hemoglobin transports approximately 23% of carbon dioxide from tissues to lungs for elimination. 1
• RBCs contain carbonic anhydrase and anion exchanger 1 (AE1/Band 3 protein), which facilitate CO₂ transport: 1
  • In tissues: CO₂ diffuses into RBCs, is hydrated by carbonic anhydrase, forms HCO₃⁻, which is then exchanged for Cl⁻ into plasma
  • In lungs: This process reverses, allowing gaseous CO₂ to be exhaled
• This mechanism is essential for maintaining systemic acid-base balance. 1

Non-Canonical Functions: Beyond Gas Transport

Blood Flow Regulation

• RBCs regulate nitric oxide (NO) bioavailability in a context-dependent manner, acting as scavengers of this vasodilator under normal conditions while storing and releasing NO during hypoxia. 1
• This dual function allows RBCs to fine-tune vascular tone and blood flow based on tissue oxygen needs. 1
• RBCs affect blood viscosity, which exponentially increases with higher hematocrit levels, directly impacting blood flow dynamics. 1

Hemostasis and Thrombosis

• RBCs contribute significantly to blood clotting through multiple mechanisms: 1
  • Altering blood viscosity and flow dynamics
  • Secreting RBC-derived microvesicles containing phosphatidylserine (PS)
  • Interacting with platelets and endothelial cells
  • Activating coagulation factors
• RBCs can produce up to 40% of thrombin in certain pathological conditions through externalized PS-mediated factor X activation. 1
• RBC-derived microvesicles induce blood clotting through Hageman factor (factor XII) activation. 1
• Under shear stress, RBCs export ATP and ADP, stimulating platelet activation and aggregation. 1

Redox Equilibrium

• Despite lacking the ability to upregulate antioxidant enzymes transcriptionally, RBCs maintain redox balance through their glutathione-based antioxidant system. 1
• RBCs scavenge and detoxify reactive oxygen species (ROS) and reactive nitrogen species (RNS) derived from neutrophils, monocytes, and endothelial cells. 1
• This antioxidant capacity is critical given that RBCs are hemoglobin- and iron-filled containers exposed to high oxidative stress. 1

Immune Response

• RBCs are immunologically active cells expressing toll-like receptor 9 (TLR9), which binds bacterial and plasmodial cell-free DNA. 1
• TLR9-mediated effects include activation of erythrophagocytosis and enhancement of innate immune response. 1
• RBCs scavenge chemokines via Duffy antigen receptor for chemokines (DARC), regulating immune cell migration. 1
• RBCs can bind pathogens directly, and extracellular hemoglobin serves as a source of ROS with bactericidal effects. 1

Clinical Implications

Systemic Metabolic Homeostasis

• RBCs function as interorgan communication systems, impacting systemic metabolic homeostasis beyond simple oxygen transport. 5, 6
• RBCs engage in complex metabolic activity and cross-talk with immune cells and other cell types. 7, 6

Pathophysiological Considerations

• RBC dysfunction contributes to cardiovascular complications, including bleeding, thromboembolic events, stroke, hypertension, and inflammation, particularly in anemia. 5
• Changes in RBC functional properties are mechanistically linked to cardiovascular disease complications. 5
• In cyanotic congenital heart disease, increased RBC mass (polycythemia) increases blood viscosity, which paradoxically limits oxygen delivery by decreasing capillary flow. 4